Deutsch
Deutschland
Anmelden
Tipp von eurobuch.com
Ähnliche Bücher
Weitere, andere Bücher, die diesem Buch sehr ähnlich sein könnten:
Buch verkaufen
Anbieter, die das Buch mit der ISBN 9781617374524 ankaufen:
Suchtools
Buchtipps
Aktuelles
FILTER
- 0 Ergebnisse
Kleinster Preis: 128,35 €, größter Preis: 245,03 €, Mittelwert: 171,19 €
Proteasome Inhibitors in Cancer Therapy - Julian Adams (Editor)
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Julian Adams (Editor):
Proteasome Inhibitors in Cancer Therapy - gebrauchtes Buch

ISBN: 9781617374524

ID: 9781617374524

Immediately upon the discovery some ten years ago that inhibition of the proteasome in cultured cells, mostly of tumor origin, caused the programmed cell death machinery to ramp up, it became imperative to investigate proteasome inhibition as a possible treatment for human cancers. In Proteasome Inhibitors in Cancer Therapy, Julian Adams, the leader in developing the field, brings together a panel of highly experienced academic and pharmaceutical investigators to take sk of the remarkable Immediately upon the discovery some ten years ago that inhibition of the proteasome in cultured cells, mostly of tumor origin, caused the programmed cell death machinery to ramp up, it became imperative to investigate proteasome inhibition as a possible treatment for human cancers. In Proteasome Inhibitors in Cancer Therapy, Julian Adams, the leader in developing the field, brings together a panel of highly experienced academic and pharmaceutical investigators to take sk of the remarkable work that has been accomplished to date, and examine emerging therapeutic possibilities for proteasome inhibitors in cancer. The topics range from a discussion of the chemistry and cell biology of the proteasome and the rationale for proteasome inhibitors in cancer to a review of current clinical trials underway. The discussion of the very empirical and practical development of rationales to test proteasome inhibitors in cancer models covers the role of the proteasome in NF-kB activation, the combining of conventional chemotherapy and radiation with proteasome inhibition, notably PS-341, new proteasome methods of inhibiting viral maturation, and the role of proteasome inhibition in the treatment of AIDS. The authors also document the development of bortezomib (Velcade™) through multicentered clinical trials in patients with relapsed and refractory myeloma to FDA approval, and describe how modern pharmacogenomic tools can be used to predict which patients will respond to such proteasome inhibitor therapy. Additional chapters on the proteasome's basic biochemistry review its mechanism in the cell cycle and apoptosis and suggest opportunities for using proteasome inhibitors to find additional medicinal targets. Authoritative and illuminating, Proteasome Inhibitors in Cancer Therapy makes clear that proteasome inhibition should prove a fertile area for the many future discoveries that will provide relief of suffering and extend the quality of life of patients afflicted Books, Medicine~~Oncology, Proteasome-Inhibitors-in-Cancer-Therapy~~Julian-Adams, 999999999, Proteasome Inhibitors in Cancer Therapy, Julian Adams (Editor), 1617374520, Springer-Verlag New York, LLC, , , , , Springer-Verlag New York, LLC

gebrauchtes bzw. antiquarisches Buch Barnesandnoble.com
MPN: , SKU 9781617374524 Versandkosten:zzgl. Versandkosten
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Proteasome Inhibitors in Cancer Therapy - Herausgegeben von Adams, Julian
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Herausgegeben von Adams, Julian:
Proteasome Inhibitors in Cancer Therapy - Taschenbuch

2010, ISBN: 9781617374524

[ED: Softcover], [PU: Springer, Berlin], A panel of leading academic and pharmaceutical investigators takes stock of the remarkable work that has been accomplished to date with proteasome inhibitors in cancer, and examines emerging therapeutic possibilities. The topics range from a discussion of the chemistry and cell biology of the proteasome and the rationale for proteasome inhibitors in cancer to a review of current clinical trials underway. The discussion of rationales for testing proteasome inhibitors in cancer models covers the role of the proteasome in NF-kB activation, the combining of conventional chemotherapy and radiation with proteasome inhibition, notably PS-341, new proteasome methods of inhibiting viral maturation, and the role of protesome inhibition in the treatment of AIDS. The authors also document the development of bortezomib (Velcade(TM)) in Phase I clinical trials and in a multicentered Phase II clinical trials in patients with relapsed and refractory myeloma.2010. 328 S. 88 SW-Abb., 8 Farbabb. 254 mmVersandfertig in 3-5 Tagen, [SC: 0.00]

Neues Buch Booklooker.de
buecher.de GmbH & Co. KG
Versandkosten:Versandkostenfrei, Versand nach Deutschland (EUR 0.00)
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Proteasome Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development) - Julian Adams (Editor)
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Julian Adams (Editor):
Proteasome Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development) - Taschenbuch

ISBN: 1617374520

ID: 11806453050

[EAN: 9781617374524], Neubuch, [PU: Humana Press]

Neues Buch Abebooks.de
ExtremelyReliable, Richmond, TX, U.S.A. [8304062] [Rating: 5 (von 5)]
NEW BOOK Versandkosten: EUR 13.89
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Proteasome Inhibitors in Cancer Therapy - Julian Adams
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Julian Adams:
Proteasome Inhibitors in Cancer Therapy - Taschenbuch

2010, ISBN: 9781617374524

Gebundene Ausgabe, ID: 16168420

Softcover reprint of hardcover 1st ed. 2004, Softcover, Buch, [PU: Humana Press Inc.]

Neues Buch Lehmanns.de
Versandkosten:Versand in 7-9 Tagen, , Versandkostenfrei innerhalb der BRD. (EUR 0.00)
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Proteasome Inhibitors in Cancer Therapy - Julian Adams
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Julian Adams:
Proteasome Inhibitors in Cancer Therapy - Taschenbuch

2010, ISBN: 9781617374524

ID: 16168420

1st ed. Softcover of orig. ed. 2004, Softcover, Buch, [PU: Humana Press Inc.]

Neues Buch Lehmanns.de
Versandkosten:Versand in 10 - 20 TagenNicht kurzfristig lieferbar, versandkostenfrei in der BRD (EUR 0.00)
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.

Details zum Buch
Proteasome Inhibitors in Cancer Therapy

A panel of leading academic and pharmaceutical investigators takes stock of the remarkable work that has been accomplished to date with proteasome inhibitors in cancer, and examines emerging therapeutic possibilities. The topics range from a discussion of the chemistry and cell biology of the proteasome and the rationale for proteasome inhibitors in cancer to a review of current clinical trials underway. The discussion of rationales for testing proteasome inhibitors in cancer models covers the role of the proteasome in NF-kB activation, the combining of conventional chemotherapy and radiation with proteasome inhibition, notably PS-341, new proteasome methods of inhibiting viral maturation, and the role of protesome inhibition in the treatment of AIDS. The authors also document the development of bortezomib (Velcade(TM)) in Phase I clinical trials and in a multicentered Phase II clinical trials in patients with relapsed and refractory myeloma.

Detailangaben zum Buch - Proteasome Inhibitors in Cancer Therapy


EAN (ISBN-13): 9781617374524
ISBN (ISBN-10): 1617374520
Gebundene Ausgabe
Taschenbuch
Erscheinungsjahr: 2010
Herausgeber: Springer-Verlag GmbH
328 Seiten
Gewicht: 0,691 kg
Sprache: eng/Englisch

Buch in der Datenbank seit 29.09.2011 10:13:21
Buch zuletzt gefunden am 15.10.2017 13:50:24
ISBN/EAN: 9781617374524

ISBN - alternative Schreibweisen:
1-61737-452-0, 978-1-61737-452-4


< zum Archiv...
Benachbarte Bücher